Skip to main content
SpringerLink
Log in

Aflibercept/brolucizumab

Intraocular inflammation and lack of efficacy

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ueji N, et al. Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment. Medicina (Kaunas, Lithuania) 59: No. 10, Oct 2023. Available from: URL: https://dx.doi.org/10.3390/medicina59101856

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/brolucizumab. Reactions Weekly 1992, 18 (2024). https://doi.org/10.1007/s40278-024-52751-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52751-1

Search

Navigation